Current through Register Vol. XLI, No. 44, November 1, 2024
Section 64-52-6 - Categories Of Potential Recipients Significantly More Vulnerable To Major Adverse Reactions6.1. Individuals who have an evolving neurologic disorder are significantly more vulnerable to major adverse reactions than is the general population.6.2. Individuals who have or had a current or previous major or other adverse reaction are significantly more vulnerable to major adverse reactions than is the general public.6.3. Infants and young children who have had previous convulsions (whether febrile or nonfebrile) are more likely to have seizures following pertussis vaccine than those without such histories, but there is no evidence that such seizures induce permanent brain damage in children.6.4. General or special use guidelines, as referenced in Section 4.2 and 5.2 should be consulted when a health care provider is considering the administration of pertussis vaccine to individuals significantly more vulnerable to major adverse reactions than the general population.